Rep. Gilbert Ray Cisneros, Jr. Acquires Alkermes plc (NASDAQ:ALKS) Stock

Key Points

• Rep. Gilbert Ray Cisneros Jr. purchased $15,001–$50,000 of Alkermes (ALKS) shares on July 30, according to a disclosure filed September 4. He also made several other stock purchases and sales in late July.
• Alkermes opened at $46.10, with a market capitalization of approximately $7.73 billion. Analysts maintain a consensus “Moderate Buy” rating and an average price target of $54.56, while several firms recently raised their targets.
• Institutional investors own 95.21% of Alkermes, but company insiders sold 87,150 shares worth about $4.33 million during the last quarter, including substantial sales by a director and an executive vice president.

Representative Gilbert Ray Cisneros, Jr. (Democratic-California) recently bought shares of Alkermes plc NASDAQ: ALKS. In a filing disclosed on September 04th, the Representative disclosed that they had bought between $15,001 and $50,000 in Alkermes stock on July 30th.

Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):

• Purchased $15,001 - $50,000 in shares of Mesabi Trust NYSE: MSB on 7/31/2026.
• Purchased $1,001 - $15,000 in shares of Praxis Precision Medicines NASDAQ: PRAX on 7/30/2026.
• Sold $15,001 - $50,000 in shares of Crinetics Pharmaceuticals NASDAQ: CRNX on 7/30/2026.
• Sold $100,001 - $250,000 in shares of Alibaba Group NYSE: BABA on 7/24/2026.
• Sold $1,001 - $15,000 in shares of Adobe NASDAQ: ADBE on 7/24/2026.
• Sold $1,001 - $15,000 in shares of Viavi Solutions NASDAQ: VIAV on 7/21/2026.
• Purchased $1,001 - $15,000 in shares of SailPoint NASDAQ: SAIL on 7/21/2026.
• Purchased $1,001 - $15,000 in shares of Glacier Bancorp NYSE: GBCI on 7/21/2026.
• Sold $1,001 - $15,000 in shares of FedEx NYSE: FDX on 7/21/2026.
• Purchased $1,001 - $15,000 in shares of Marvell Technology NASDAQ: MRVL on 7/17/2026.

Alkermes Stock Performance

NASDAQ:ALKS opened at $46.10 on Tuesday. The stock has a 50-day simple moving average of $50.43 and a 200-day simple moving average of $41.04. The stock has a market cap of $7.73 billion, a P/E ratio of 121.32 and a beta of 0.31. Alkermes plc has a 1 year low of $25.17 and a 1 year high of $55.67. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.85 and a current ratio of 2.30.

Analyst Upgrades and Downgrades

ALKS has been the topic of a number of research reports. Stifel Nicolaus restated a "buy" rating and set a $63.00 price target (up from $45.00) on shares of Alkermes in a research note on Monday, July 20th. Mizuho increased their price objective on Alkermes from $53.00 to $65.00 and gave the company an "outperform" rating in a report on Thursday, July 2nd. JPMorgan Chase & Co. raised their target price on shares of Alkermes from $60.00 to $61.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 29th. Royal Bank Of Canada lifted their target price on shares of Alkermes from $45.00 to $56.00 and gave the company an "outperform" rating in a report on Tuesday, June 9th. Finally, Weiss Ratings reiterated a "hold (c)" rating on shares of Alkermes in a research report on Friday, August 7th. One investment analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $54.56.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of ALKS. Ameritas Advisory Services LLC bought a new position in shares of Alkermes in the second quarter valued at about $39,000. Cullen Frost Bankers Inc. acquired a new position in shares of Alkermes during the fourth quarter valued at $28,000. Johnson Financial Group Inc. bought a new position in Alkermes in the third quarter valued at about $31,000. UMB Bank n.a. increased its position in Alkermes by 57.6% in the fourth quarter. UMB Bank n.a. now owns 1,220 shares of the company's stock worth $34,000 after purchasing an additional 446 shares during the period. Finally, Northwestern Mutual Wealth Management Co. raised its holdings in Alkermes by 1,041.4% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 1,324 shares of the company's stock worth $37,000 after purchasing an additional 1,208 shares during the last quarter. 95.21% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Alkermes

In other Alkermes news, Director Nancy Lynn Md Snyderman sold 44,472 shares of the stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $50.35, for a total value of $2,239,165.20. Following the transaction, the director owned 15,395 shares of the company's stock, valued at approximately $775,138.25. This represents a 74.28% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Craig Hopkinson sold 9,000 shares of Alkermes stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $51.51, for a total transaction of $463,590.00. Following the transaction, the executive vice president directly owned 73,389 shares in the company, valued at $3,780,267.39. The trade was a 10.92% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 87,150 shares of company stock worth $4,332,413. Insiders own 4.59% of the company's stock.

About Representative Cisneros

Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California's 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027. Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California's 31st Congressional District. He declared candidacy for the 2026 election. Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor's degree in political science from George Washington University in 1994, a master's in business administration from Regis University in 2002, and a master's degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.

Alkermes Company Profile

Alkermes plc is a biopharmaceutical company focused on developing innovative medicines to address unmet needs in the central nervous system (CNS). The company applies its proprietary drug delivery technologies and therapeutic expertise to advance treatments for addiction, schizophrenia, bipolar I disorder and depression. Alkermes' portfolio includes both commercial products and a pipeline of investigational therapies designed to improve patient outcomes and support long-term disease management.

Alkermes' commercial franchise features several approved products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.